Question: why is amrn stock dropping?
Answer: Amarin's stock dropped 70% after its patent for Vascepa was invalidated by a federal judge. ... On Monday, Amarin (NASDAQ:AMRN) investors got some horrible news. A federal judge in Nevada declared that the company's intellectual property was "obvious" and its drug patent was invalid.